Pharma companies challenge GSK/Teva patent settlement

Davide Mamone

06 February 2023

Credit: Ian Wilson via flickr

GlaxoSmithKline and Teva Pharmaceuticals conspired to delay generic competition for an epilepsy drug, a slew of direct purchasers including AmerisourceBergen and McKesson have argued.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Davide Mamone

View full biography

Author | News reporter, GCR USA

[email protected]

Tipline

Labour is painful: The Tipline for 23 March 2023
The Department of Justice has a labour problem – and it's not just the need for additional staff. The Antitrust Division lost its third consecutive criminal labour case on Wednesday after a federal jury in Maine acquitted owners of four home healthcare staffing companies of price-fixing and no-poach charges. Counsel to one of the defendants said the jury "clearly" understood that the charges were “grossly unfair”. Also in Tipline, the FTC has its head …
For everything, there is a season: The Tipline for 22 March 2023
Keeping up with the Jones: The Tipline for 21 March 2023

Pharma companies challenge GSK/Teva patent settlement

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Davide Mamone